Chemerin levels in metabolic syndrome: a promising biomarker

References

• Adams-Huet, B., et al., 2014. Increased adipose tissue insulin resistance in metabolic syndrome: relationship to circulating adipokines. Metabolic syndrome and related disorders, 12 (10), 503–507.
   PubMed Web of Science ®Google Scholar
• Aguilar, M., et al., 2015. Prevalence of the metabolic syndrome in the United States, 2003–2012. Journal of American medical association, 313 (19), 1973–1974.
   PubMed Web of Science ®Google Scholar
• Aksan, G., et al., 2014. Association of serum chemerin levels with severity of coronary artery disease in patients with metabolic syndrome. International journal of clinical and experimental medicine, 7 (12), 5461–5468.
   PubMed Web of Science ®Google Scholar
• Alberti, K.G.M.M., International Association for the Study of Obesity., et al., 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120 (16), 1640–1645.
   PubMed Web of Science ®Google Scholar
• Ashtary-Larky, D., et al., 2021. The effect of exercise training on serum concentrations of chemerin in patients with metabolic diseases: a systematic review and meta-analyses. Archives of physiology and biochemistry. doi:10.1080/13813455.2021.1892148
   Web of Science ®Google Scholar
• Bobbert, T., et al., 2015. Chemerin and prediction of diabetes mellitus type 2. Clinical Endocrinology, 82 (6), 838–843.
   PubMed Web of Science ®Google Scholar
• Bozaoglu, K., et al., 2007. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology, 148 (10), 4687–4694.
   PubMed Web of Science ®Google Scholar
• Bozaoglu, K., et al., 2009. Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. The journal of clinical endocrinology & metabolism, 94 (8), 3085–3088.
   PubMed Web of Science ®Google Scholar
• Buechler, C., et al., 2019. Chemerin isoforms and activity in obesity. International journal of molecular sciences, 20 (5), 1128.
   PubMed Web of Science ®Google Scholar
• Chakaroun, R., et al., 2012. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metabolism: clinical and experimental, 61 (5), 706–714.
   PubMed Web of Science ®Google Scholar
• Chu, S.H., et al., 2012. Chemerin and adiponectin contribute reciprocally to metabolic syndrome. PLoS One, 7 (4), e34710.
   PubMed Web of Science ®Google Scholar
• Dong, B., Ji, W., and Zhang, Y., 2011. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Internal Medicine, 50 (10), 1093–1097.
   PubMed Web of Science ®Google Scholar
• Ernst, M.C., and Sinal, C.J., 2010. Chemerin: at the crossroads of inflammation and obesity. Trends in endocrinology and metabolism, 21 (11), 660–667.
   PubMed Web of Science ®Google Scholar
• Fatima, S.S., et al., 2014. New roles of the multidimensional adipokine: chemerin. Peptides, 62, 15–20.
   PubMed Web of Science ®Google Scholar
• Goralski, K.B., et al., 2007. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. The journal of biological chemistry, 282 (38), 28175–28188.
   PubMed Web of Science ®Google Scholar
• Grundy, S.M., National Heart, Lung, and Blood Institute, et al., 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific statement. Circulation, 112 (17), 2735–2752.
   PubMed Web of Science ®Google Scholar
• Gurung, P., et al., 2019. Increased mast cell abundance in adipose tissue of metabolic syndrome: relevance to the proinflammatory state and increased adipose tissue fibrosis. American journal of physiology-endocrinology and metabolism, 316 (3), E504–E509.
   PubMed Web of Science ®Google Scholar
• Hashemi, M., et al., 2012. Association between chemerin rs17173608 and vaspin rs2236242 gene polymorphisms and the metabolic syndrome, a preliminary report. Gene, 510 (2), 113–117.
   PubMed Web of Science ®Google Scholar
• Helfer, G., and Wu, Q.-F., 2018. Chemerin: a multifaceted adipokine involved in metabolic disorders. The journal of endocrinology, 238 (2), R79–R94.
   PubMed Web of Science ®Google Scholar
• Jialal, I., et al., 2017. Increased fibrosis and angiogenesis in subcutaneous gluteal adipose tissue in nascent metabolic syndrome. Diabetes & Metabolism, 43 (4), 364–367.
   PubMed Web of Science ®Google Scholar
• Jialal, I., et al., 2013. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. The journal of clinical endocrinology and metabolism, 98 (3), E514–517.
   PubMed Web of Science ®Google Scholar
• Jialal, I., and Devaraj, S., 2018. Subcutaneous adipose tissue biology in metabolic syndrome. Hormone molecular biology and clinical investigation, 33 (1). doi:10.1515/hmbci-2017-0074
   PubMed Web of Science ®Google Scholar
• Kaur, J., et al., 2018. Chemerin in human cardiovascular disease. Vascular pharmacology, 110, 1–6.
   PubMed Web of Science ®Google Scholar
• Li, Y., Shi, B., and Li, S., 2014. Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis. PLoS One, 9 (12), e113915.
   PubMed Web of Science ®Google Scholar
• Mehanna, E.T., et al., 2016. Association of chemerin Rs17173608 and vaspin Rs2236242 gene polymorphisms with metabolic syndrome in Egyptian women. Endocrine research, 41 (1), 43–48.
   PubMed Web of Science ®Google Scholar
• Moussa, K., et al., 2019. Increased eosinophils in adipose tissue of metabolic syndrome. Journal of diabetes and its complications, 33 (8), 535–538.
   PubMed Web of Science ®Google Scholar
• Pahwa, R., et al., 2021. Increased Inflammasome activity in subcutaneous adipose tissue of patients with metabolic syndrome. Diabetes/Metabolism research and reviews, 37 (3), e3383.
   PubMed Web of Science ®Google Scholar
• Rourke, J.L., Dranse, H.J., and., and Sinal, C.J., 2013. Towards an integrative approach to understanding the role of chemerin in human health and disease. Obesity Reviews, 14 (3), 245–262.
   PubMed Web of Science ®Google Scholar
• Samson, S.L., and Garber, A.J., 2014. Metabolic syndrome. Endocrinology and metabolism clinics of North America, 43 (1), 1–23.
   PubMed Web of Science ®Google Scholar
• Shafer-Eggleton, J., Adams-Huet, B., and., and Jialal, I., 2020. Chemerin ratios to HDL-cholesterol and adiponectin as biomarkers of metabolic syndrome. Endocrine research, 45 (4), 241–245.
   PubMed Web of Science ®Google Scholar
• Stejskal, D., et al., 2008. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population – a pilot study. Biomedical papers, 152 (2), 217–221.
   PubMed Web of Science ®Google Scholar
• Wang, D., et al., 2013. Plasma Chemerin level in metabolic syndrome. Genetics and molecular research, 12 (4), 5986–5991.
   PubMed Web of Science ®Google Scholar